Judge Vassiliki Thanou was sworn in Friday as Greece's first female prime minister, heading a caretaker government until elections are held.» Read More
The iPhone may lose its luster a few decades from now, LVMH baron Bernard Arnault tells CNBC, but people will still drink Dom Pérignon.
Since the start of the Ukrainian conflict, Russia has increased its air activity over the Pacific Ocean, near California and the island of Guam.
France’s finance minister has called for debate about the strength of the euro, as the currency neared a seven-week peak on Tuesday.
AstraZeneca, the pharmaceutical company fighting off repeated approaches from larger rival Pfizer, has boosted its defense against the raid.
Business activity in the euro zone boosted by new orders, increasing backlogs of work and employment returning to growth, new data shows.
Complacency by policymakers is one of the biggest risks to the world's economy, the head of the OECD told CNBC, as the organization cut its global growth forecast for 2014.
Bayer will acquire the consumer care business of U.S.-based Merck & Co for $14.2 billion in cash, the company said in a statement Tuesday.
Fincantieri will apply to list in Milan as early as Tuesday, in what officials predict will be Italy's largest privatization program since the 1990s.
Barclays reported a 5 percent fall in adjusted pre-tax profit to £1.7 billion ($2.9 billion), as the fixed-income division of its investment bank slowed dramatically.
Waterproof phones are coming - and they're just one example of how technology is transforming the manufacturing sector.
Swiss lender UBS posted better-than-expected first-quarter profit as CEO Sergio Ermotti pledged to pay a special dividend to investors.
France rejected GE's bid for Alstom's energy assets, but opened the door for a deal that would also combine the two companies' rail businesses.
Tensions over Ukraine have been simmering for weeks and now threaten to spill over into a much deeper risk-off mood in global financial markets.
Pfizer, one of the world's biggest drugs firms, may have had a $106 billion takeover bid for rival AstraZeneca rejected, but analysts expect it to get its way in the end.
The EU's energy chief warned Moscow that the Ukraine crisis was hardening Brussels' stance on a gas pipeline that Russia is planning to build.
France is under renewed pressure to cut its budget deficit, after the European Commission forecast it would miss its 2015 reduction target.
France continues to blame the rest of the world for its woes, Pascal Lamy, the French former head of the World Trade Organisation, told CNBC.
French members of Parliament are being encouraged to go on work placements in an effort to boost their understanding of the business world.
Investors and policymakers worldwide are braced for a shake-up of global markets, due to heightening tensions and sanctions in Ukraine and Russia.
Pfizer reported revenues well below Wall Street expectations, hurt by falling sales of generic medicines it calls established pharmaceuticals.
Get the best of CNBC in your inbox
CNBC breaks down the five big stories to keep an eye out for the coming week.
Daniel Tenengauzer, head of EM and global FX strategy at RBC, explains why the carnage in currencies for emerging markets isn't over.
Todd Horwitz, author and founder at Averagejoeoptions.com, gives the rundown ahead of the U.S. open on August 28 2015.